Compare MDCX & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDCX | NSYS |
|---|---|---|
| Founded | 2008 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 40.1M |
| IPO Year | 2025 | 1996 |
| Metric | MDCX | NSYS |
|---|---|---|
| Price | $0.17 | $11.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 5.3M | 16.8K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.85 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $14,371,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $128.78 |
| Revenue Growth | N/A | ★ 7.01 |
| 52 Week Low | $0.14 | $6.50 |
| 52 Week High | $3.05 | $18.01 |
| Indicator | MDCX | NSYS |
|---|---|---|
| Relative Strength Index (RSI) | 34.28 | 46.62 |
| Support Level | $0.15 | $11.23 |
| Resistance Level | $0.36 | $12.69 |
| Average True Range (ATR) | 0.02 | 0.52 |
| MACD | 0.00 | 0.12 |
| Stochastic Oscillator | 22.96 | 57.11 |
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.